Application 202869

Type
ANDA
Sponsor
HOSPIRA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LEVETIRACETAMLEVETIRACETAMINJECTABLE;INTRAVENOUS500MG/5ML (100MG/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-1886LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent
0409-2011LEVETIRACETAMLEVETIRACETAMHospira, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
22901ORIG2012-10-09